Senate Democrats took their first step Wednesday toward the creation of its proposed Prescription Drug Affordability Board by reporting legislation from the Senate Finance, Insurance and Consumer Protection Committee.
All three bills (SB 483 Track, SB 484 Trackand SB 485 Track) were reported 5-2. Committee Democrats voted yes while Sen. Kevin Daley (R-Lum) and Sen. Lana Theis (R-Brighton) voted no. Sen. Mark Huizenga (R-Walker), the committee’s minority vice chair, abstained on all three bills, citing a possible conflict of interest.
Read the full article here
(248) 520-2329
